Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
6.21
+0.27 (4.55%)
At close: Oct 8, 2025, 4:00 PM EDT
6.21
0.00 (0.00%)
After-hours: Oct 8, 2025, 7:00 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $168.15 million as of October 8, 2025. Its market cap has decreased by -54.44% in one year.
Market Cap
168.15M
Enterprise Value
45.87M
1-Year Change
-54.44%
Ranking
Category
Stock Price
$6.21
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $168.15M, a decrease of -68.20%. That is a compound annual growth rate of -49.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 160.84M | 40.98% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |